Strategic branding shift Optimal Research is now operating under the Accelerated Enrollment Solutions (AES) umbrella, signaling a transformation that positions the company to offer enhanced enrollment and site services. This creates an opportunity to discuss integrated clinical trial acceleration solutions with potential sponsors seeking faster timelines and better budgeting.

Acquisition history The acquisition by Synexus and integration into AES suggests established credibility and a broader network. Leverage this lineage to engage sponsors looking for a proven global site network and access to dedicated research sites with specialist capabilities.

Mid-market footprint Current employee count and revenue indicate a mid-sized operation with room to scale. Target medium to large sponsors seeking nimble, cost-efficient enrollment and site management, offering the ability to partner for rapid trial enrollment without the overhead of a mega-vendor.

Digital engagement tools The tech stack includes analytics, tag management, marketing automation, and tracking tools (Google Analytics, GA Manager, HubSpot, Facebook Pixel). This enables data-driven outreach, lead scoring, and measurement of enrollment marketing effectiveness to optimize sponsor proposals.

Expansion-ready capabilities As part of AES, Optimal Research can offer combined site and enrollment services to deliver faster trial timelines and higher patient reach. This positions the company to pitch comprehensive, end-to-end enrollment acceleration as a differentiator to sponsors facing patient recruitment bottlenecks.